Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 633

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 3
Chunk 633
---
 Position

			Fiscal Year

			Salary ($)

			Bonus ($)

			Stock Awards ($) (1)

			All Other Compensation ($)

			Total ($)

			Pardeep Nijhawan, MD

			2025

			$
			357,696
			(2)
			 
			$
			93,717

			$
			522,931
			(3)
			 
			$
			32,415
			(4)
			 
			$
			1,006,759

			Director, Chief Executive Officer and Corporate Secretary

			2024

			357,696
			(5) 

			72,434

			-

			34,598
			(4) 

			464,728

			Michael Brooks, PhD

			2025

			335,340

			87,859

			411,671
			(6)

			27,007
			(7) 

			861,877

			President

			2024

			335,340

			67,906

			-

			25,741
			(7) 

			428,987

			Peter Weiler (8)

			2025

			125,000

			-

			129,143
			(9)

			10,558
			(10) 

			264,701

			Chief Financial Officer

			Stephen Lemieux, CPA (11)

			2025

			192,500

			86,460

			111,858
			(12)

			32,054
			(13) 

			422,872

			Former Chief Financial Of icer

			2024

			330,000

			14,097

			-

			24,000
			(13) 

			368,097

			(1)
			
			The amounts shown in this column represent the aggregate grant date fair value of the restricted share units computed in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 718, not the actual amounts paid to or realized by the named executive officers during the covered fiscal year. The assumptions used in determining grant date fair value of